Hepatitis B trials in Hong Kong

2 of 11 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseEnrolling by invitation
  A Long-term Observational Study in Participants Who Have Received PBGENE-HBV

  Where

  Hong Kong

  Age

  19 years to 80 years

  People

  45 worldwide

  Run by

  Precision BioSciences, Inc.

  See details and how to joinNCT07254208
• No phaseTaking people
  Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

  Where

  Hong Kong, Shatin

  Age

  20 years to 70 years

  People

  50 worldwide

  Run by

  Arbutus Biopharma Corporation

  See details and how to joinNCT06277037